Login
From:
ascopost.com
(Uncensored)
subscribe
Revumenib in Triplet Regimen Under Study in Newly Diagnosed AML With NPM1-KMT2A Alterations - The ASCO Post
https://ascopost.com/news/june-2025/revumenib-in-triplet-regimen-under-study-in-newly-diagnosed-aml-with-npm1-kmt2a-alterations/
links
backlinks
Tagged with:
news coverage
clinical research program
joshua zeidner
leukemia clinical program
A new combination of azacitidine, venetoclax, and revumenib demonstrated high rates of complete response and clinical activity in older adults with newly diagnosed acute myeloid leukemia and an NPM1 m...
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
